Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki

Makiko Horai, Shinya Satoh, Masatoshi Matsuo, Masako Iwanaga, Kensuke Horio, Tatsuro Jo, Yumi Takasaki, Yasuhisa Kawaguchi, Hideki Tsushima, Shinichiro Yoshida, Masataka Taguchi, Hidehiro Itonaga, Yasushi Sawayama, Jun Taguchi, Yoshitaka Imaizumi, Tomoko Hata, Yukiyoshi Moriuchi, Detlef Haase, Koh-Ichiro Yoshiura, Yasushi Miyazaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The myelodysplastic syndromes (MDS) are clonal haematopoietic disorders that develop de novo and also secondary to chemotherapy and/or radiation therapy. We previously demonstrated that the risk of MDS is increased among atomic bomb survivors with significant correlation to radiation dose; however, the clinical characteristics of these survivors have not been well analysed. In this study, we investigated chromosomal abnormalities of MDS among survivors. The frequency of abnormal karyotypes was significantly higher, with more very poor risk karyotypes, according to the revised International Prognostic Scoring System, among those exposed close to the hypocentre compared with unexposed cases. However, abnormal karyotype frequency did not reflect the prognosis of exposed cases with respect to distance from the hypocentre. In addition, there was no difference in prognosis between exposed and unexposed cases. Among proximally exposed cases (<1·5 km from the hypocentre), chromosomal translocations and inversions were more frequent, and the frequency of structural alterations in chromosomes 3, 8, and 11 was significantly increased compared with unexposed cases. These results suggest that chromosomal alterations in MDS among survivors have different features compared with those in de novo or therapy-related MDS. Detailed molecular study is warranted.

Original languageEnglish
Pages (from-to)381-390
Number of pages10
JournalBritish Journal of Haematology
Volume180
Issue number3
DOIs
Publication statusPublished - Feb 2018
Externally publishedYes

Fingerprint

Nuclear Weapons
Myelodysplastic Syndromes
Abnormal Karyotype
Chromosomes, Human, Pair 8
Genetic Translocation
Chromosomes, Human, Pair 11
Chromosomes, Human, Pair 3
Karyotype
Chromosome Aberrations
Radiotherapy
Radiation
Drug Therapy

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Cell Count
  • Bone Marrow/pathology
  • Chromosome Aberrations
  • Cytogenetic Analysis
  • Disaster Victims
  • Female
  • Humans
  • Japan/epidemiology
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes/diagnosis
  • Nuclear Weapons
  • Patient Outcome Assessment
  • Registries
  • Survival Analysis
  • Survivors

Cite this

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki. / Horai, Makiko; Satoh, Shinya; Matsuo, Masatoshi; Iwanaga, Masako; Horio, Kensuke; Jo, Tatsuro; Takasaki, Yumi; Kawaguchi, Yasuhisa; Tsushima, Hideki; Yoshida, Shinichiro; Taguchi, Masataka; Itonaga, Hidehiro; Sawayama, Yasushi; Taguchi, Jun; Imaizumi, Yoshitaka; Hata, Tomoko; Moriuchi, Yukiyoshi; Haase, Detlef; Yoshiura, Koh-Ichiro; Miyazaki, Yasushi.

In: British Journal of Haematology, Vol. 180, No. 3, 02.2018, p. 381-390.

Research output: Contribution to journalArticle

Horai, M, Satoh, S, Matsuo, M, Iwanaga, M, Horio, K, Jo, T, Takasaki, Y, Kawaguchi, Y, Tsushima, H, Yoshida, S, Taguchi, M, Itonaga, H, Sawayama, Y, Taguchi, J, Imaizumi, Y, Hata, T, Moriuchi, Y, Haase, D, Yoshiura, K-I & Miyazaki, Y 2018, 'Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki', British Journal of Haematology, vol. 180, no. 3, pp. 381-390. https://doi.org/10.1111/bjh.15050
Horai, Makiko ; Satoh, Shinya ; Matsuo, Masatoshi ; Iwanaga, Masako ; Horio, Kensuke ; Jo, Tatsuro ; Takasaki, Yumi ; Kawaguchi, Yasuhisa ; Tsushima, Hideki ; Yoshida, Shinichiro ; Taguchi, Masataka ; Itonaga, Hidehiro ; Sawayama, Yasushi ; Taguchi, Jun ; Imaizumi, Yoshitaka ; Hata, Tomoko ; Moriuchi, Yukiyoshi ; Haase, Detlef ; Yoshiura, Koh-Ichiro ; Miyazaki, Yasushi. / Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki. In: British Journal of Haematology. 2018 ; Vol. 180, No. 3. pp. 381-390.
@article{ca02495fba1241219a45a65f4eae4bc0,
title = "Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki",
abstract = "The myelodysplastic syndromes (MDS) are clonal haematopoietic disorders that develop de novo and also secondary to chemotherapy and/or radiation therapy. We previously demonstrated that the risk of MDS is increased among atomic bomb survivors with significant correlation to radiation dose; however, the clinical characteristics of these survivors have not been well analysed. In this study, we investigated chromosomal abnormalities of MDS among survivors. The frequency of abnormal karyotypes was significantly higher, with more very poor risk karyotypes, according to the revised International Prognostic Scoring System, among those exposed close to the hypocentre compared with unexposed cases. However, abnormal karyotype frequency did not reflect the prognosis of exposed cases with respect to distance from the hypocentre. In addition, there was no difference in prognosis between exposed and unexposed cases. Among proximally exposed cases (<1·5 km from the hypocentre), chromosomal translocations and inversions were more frequent, and the frequency of structural alterations in chromosomes 3, 8, and 11 was significantly increased compared with unexposed cases. These results suggest that chromosomal alterations in MDS among survivors have different features compared with those in de novo or therapy-related MDS. Detailed molecular study is warranted.",
keywords = "Adult, Aged, Aged, 80 and over, Blood Cell Count, Bone Marrow/pathology, Chromosome Aberrations, Cytogenetic Analysis, Disaster Victims, Female, Humans, Japan/epidemiology, Male, Middle Aged, Myelodysplastic Syndromes/diagnosis, Nuclear Weapons, Patient Outcome Assessment, Registries, Survival Analysis, Survivors",
author = "Makiko Horai and Shinya Satoh and Masatoshi Matsuo and Masako Iwanaga and Kensuke Horio and Tatsuro Jo and Yumi Takasaki and Yasuhisa Kawaguchi and Hideki Tsushima and Shinichiro Yoshida and Masataka Taguchi and Hidehiro Itonaga and Yasushi Sawayama and Jun Taguchi and Yoshitaka Imaizumi and Tomoko Hata and Yukiyoshi Moriuchi and Detlef Haase and Koh-Ichiro Yoshiura and Yasushi Miyazaki",
note = "{\circledC} 2017 John Wiley & Sons Ltd.",
year = "2018",
month = "2",
doi = "10.1111/bjh.15050",
language = "English",
volume = "180",
pages = "381--390",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki

AU - Horai, Makiko

AU - Satoh, Shinya

AU - Matsuo, Masatoshi

AU - Iwanaga, Masako

AU - Horio, Kensuke

AU - Jo, Tatsuro

AU - Takasaki, Yumi

AU - Kawaguchi, Yasuhisa

AU - Tsushima, Hideki

AU - Yoshida, Shinichiro

AU - Taguchi, Masataka

AU - Itonaga, Hidehiro

AU - Sawayama, Yasushi

AU - Taguchi, Jun

AU - Imaizumi, Yoshitaka

AU - Hata, Tomoko

AU - Moriuchi, Yukiyoshi

AU - Haase, Detlef

AU - Yoshiura, Koh-Ichiro

AU - Miyazaki, Yasushi

N1 - © 2017 John Wiley & Sons Ltd.

PY - 2018/2

Y1 - 2018/2

N2 - The myelodysplastic syndromes (MDS) are clonal haematopoietic disorders that develop de novo and also secondary to chemotherapy and/or radiation therapy. We previously demonstrated that the risk of MDS is increased among atomic bomb survivors with significant correlation to radiation dose; however, the clinical characteristics of these survivors have not been well analysed. In this study, we investigated chromosomal abnormalities of MDS among survivors. The frequency of abnormal karyotypes was significantly higher, with more very poor risk karyotypes, according to the revised International Prognostic Scoring System, among those exposed close to the hypocentre compared with unexposed cases. However, abnormal karyotype frequency did not reflect the prognosis of exposed cases with respect to distance from the hypocentre. In addition, there was no difference in prognosis between exposed and unexposed cases. Among proximally exposed cases (<1·5 km from the hypocentre), chromosomal translocations and inversions were more frequent, and the frequency of structural alterations in chromosomes 3, 8, and 11 was significantly increased compared with unexposed cases. These results suggest that chromosomal alterations in MDS among survivors have different features compared with those in de novo or therapy-related MDS. Detailed molecular study is warranted.

AB - The myelodysplastic syndromes (MDS) are clonal haematopoietic disorders that develop de novo and also secondary to chemotherapy and/or radiation therapy. We previously demonstrated that the risk of MDS is increased among atomic bomb survivors with significant correlation to radiation dose; however, the clinical characteristics of these survivors have not been well analysed. In this study, we investigated chromosomal abnormalities of MDS among survivors. The frequency of abnormal karyotypes was significantly higher, with more very poor risk karyotypes, according to the revised International Prognostic Scoring System, among those exposed close to the hypocentre compared with unexposed cases. However, abnormal karyotype frequency did not reflect the prognosis of exposed cases with respect to distance from the hypocentre. In addition, there was no difference in prognosis between exposed and unexposed cases. Among proximally exposed cases (<1·5 km from the hypocentre), chromosomal translocations and inversions were more frequent, and the frequency of structural alterations in chromosomes 3, 8, and 11 was significantly increased compared with unexposed cases. These results suggest that chromosomal alterations in MDS among survivors have different features compared with those in de novo or therapy-related MDS. Detailed molecular study is warranted.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Blood Cell Count

KW - Bone Marrow/pathology

KW - Chromosome Aberrations

KW - Cytogenetic Analysis

KW - Disaster Victims

KW - Female

KW - Humans

KW - Japan/epidemiology

KW - Male

KW - Middle Aged

KW - Myelodysplastic Syndromes/diagnosis

KW - Nuclear Weapons

KW - Patient Outcome Assessment

KW - Registries

KW - Survival Analysis

KW - Survivors

U2 - 10.1111/bjh.15050

DO - 10.1111/bjh.15050

M3 - Article

C2 - 29265181

VL - 180

SP - 381

EP - 390

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -